Orphina Biotechnology
PrivateCompany Overview
Orphina Biotechnology operates in Healthcare & Life Sciences and is based in Calabasas, California. It was founded in 2020.
Orphina Biotechnology is a biotechnology company that develops gene therapies for preserving and prolonging muscle health, with an initial focus on GNE myopathy.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Orphina Biotechnology Comparables
Compare Orphina Biotechnology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Genosera Inc. | 86% | |
| Myosana Therapeutics | 84% | |
| Spot Biosystems | 82% |
For institutional investors. Book with your work email.
Orphina Biotechnology Funding Rounds
Historical fundraising activity
Orphina Biotechnology Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Orphina Biotechnology's valuation, stock price, and market status.
Is Orphina Biotechnology a public or private company?
Orphina Biotechnology is a private company.
What is the current stock price of Orphina Biotechnology?
Orphina Biotechnology is a private company, so its shares have no public market price. Caplight tracks Orphina Biotechnology's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Orphina Biotechnology worth (valuation)?
Valuation information for Orphina Biotechnology is not publicly available.
Can I buy Orphina Biotechnology stock?
Orphina Biotechnology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Orphina Biotechnology's last funding round?
Funding round information for Orphina Biotechnology is not publicly available.
Who are the main investors in Orphina Biotechnology?
Investor information for Orphina Biotechnology is not publicly disclosed.
Will Orphina Biotechnology IPO soon?
No public IPO plans have been announced for Orphina Biotechnology.
How can I track Orphina Biotechnology secondary market activity?
Caplight tracks bids, offers, and trades in Orphina Biotechnology's shares on secondary markets.